We are thrilled to announce our March webinar on 3/29, 11:00 a.m. - 12 p.m., will feature Dr. Art Caplan and his perspectives on COVID-19 as a turning point. Please see a description below and click on this link to save the event and Zoom details to your calendar (also provided below).
We hope you’ll join us for this interesting, interactive webinar and a wonderful opportunity to engage with Dr. Caplan!
Karla Childers, Lindsay McNair, Marcin Dudek
DIA Bioethics Community Leadership Team
Description:
The drug development world certainly felt the immediate impact of the COVID-19 pandemic. But we are only just beginning to think about the long-term impacts of how the policies, practices and principles that we relied on during 2020 will continue to shape clinical research and drug development practices for years to come. In addition to the operations challenges, COVID-19 also brought us new ethical challenges, which will also continue to resonate through the future of the drug development community.
In this webinar, internationally-known bioethicist Dr. Art Caplan will discuss bioethical issues that came into new focus in 2020 that continue to be significant. Issues to be discussed will include:
· scientific communication by pre-print and
press release;
· empowering patient advocacy groups who have
seen the potential speed of making new therapies available to patients
· long-term impacts on clinical trial design
considerations
· informed consent in emergency settings and for
unapproved products under EUA
· Human challenge studies
Dr. Art Caplan is the Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine in New York City.
Prior to coming to NYU, Art was the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania Perelman School of Medicine in Philadelphia, where he created the Center for Bioethics and the Department of Medical Ethics. Art is the author or editor of thirty-five books and over 725 papers in peer reviewed journals. He has served on several national and international committees, and he is currently, among other things, a member of the University of Pennsylvania’s External Advisory Committee for its Orphan Disease Center, a member of the Ethics and Ebola Working Group of the World Health Organization. He is also an internationally recognized expert in the field of compassionate use and pre-approval access and he founded and chairs the committee which advises Johnson & Johnson’s Janssen Pharmaceuticals about requests for compassionate use of some of its investigational medicines. He holds seven honorary degrees from colleges and medical schools and is a fellow of the multiple academies and associations. He has also received the Lifetime Achievement Award from the American Society of Bioethics and the Humanities. He is a frequent commentator on CNN.
Join Zoom Meeting
https://diaglobal.zoom.us/j/95604492108?pwd=RmJXTDF0OUVZWU1yWHQrZFFDNEZvQT09
Meeting ID: 956 0449 2108
Passcode: 897541
One tap mobile
+13017158592,,95604492108#,,,,*897541# US (Washington DC)
+13126266799,,95604492108#,,,,*897541# US (Chicago)
Find your local number: https://diaglobal.zoom.us/u/abx49OsDCS
--------------------
https://zoom.us/meeting/tJErd-2spzkrGtwKx_bNE08RX2S--CvqFGBA/ics
https://diaglobal.zoom.us/j/95604492108?pwd=RmJXTDF0OUVZWU1yWHQrZFFDNEZvQT09
https://diaglobal.zoom.us/u/abx49OsDCS